Enterprise AI Analysis
Introducing FREMML: a decision-support approach for automated identification of individuals at high imminent fracture risk
This study leveraged explainable AI to enhance the Danish FREM model, a predictive tool for one-year major osteoporotic fracture risk, across over 2.4 million individuals aged 45 and above. By employing a DART boosting algorithm, the model achieved an improved AUC of 0.77. The integration of explainable outputs, such as SHAP values, significantly aids clinical interpretation and facilitates targeted referrals for fracture risk assessments. This enhanced model, FREMML, offers a superior, transparent, and clinically applicable decision-support approach for identifying high-risk individuals for DXA scans, potentially improving early detection and prevention of fractures.
Key AI Impact Metrics
Implementing the FREMML model in a healthcare system like Denmark can lead to substantial improvements in patient care and operational efficiency. The automated identification of high-risk individuals allows for proactive intervention, reducing the incidence of severe fractures and associated healthcare costs. The explainable AI components provide clinicians with clear insights, fostering trust and enabling more informed decision-making. This translates to fewer hospitalizations, better patient outcomes, and optimized resource allocation.
0.77
Improved predictive performance over previous FREM models
2.4M+
Individuals screened for fracture risk
15 years
Look-back period for data extraction
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Model Performance
Explainable AI (XAI)
Clinical Implications
FREMML showed superior performance (AUC 0.77) compared to previous versions, highlighting the effectiveness of the DART boosting algorithm in predicting one-year MOF risk. Age and sex were key predictors, with advanced feature engineering contributing significantly. Stratified analyses revealed varying performance across age groups and poorer prediction in males.
The integration of explainable AI, specifically Shapley Additive exPlanations (SHAP) values, allowed for clinical interpretation of relative MOF risk. This transparency helps physicians understand model decisions, facilitating more informed referrals for DXA scans and enhancing trust in the AI-driven decision support.
FREMML offers a robust decision-support tool for primary care, enabling automated identification of high-risk individuals for fractures. Combined with XAI, it provides actionable insights that can guide physician referrals to DXA, promoting early detection and prevention of major osteoporotic fractures in an an aging population. Future work includes calibration and external validation across other Nordic countries.
69.2%
Sensitivity at Youden's threshold
Enterprise Process Flow
Data Extraction (Registry Data)
→
Feature Engineering (15-year lookback)
→
DART Boosting Algorithm Training
→
Model Validation (AUC 0.77)
→
Explainable AI (SHAP Values)
→
Clinical Interpretation & Referral Guidance
| Feature | FREMML (Current Study) | Previous FREM (Logistic Regression) |
|---|---|---|
| Algorithm |
|
|
| Performance (AUC) |
|
|
| Explainability |
|
|
| Data Input |
|
|
Case Study: Automated High-Risk Identification in Primary Care
Challenge: A primary care physician struggled to efficiently identify all individuals at high imminent fracture risk among their large patient population without manual review of extensive medical histories.
Solution: Implementing FREMML provided an automated weekly report flagging patients with a high one-year MOF risk. The report included personalized SHAP values explaining why each patient was flagged.
Outcome: The physician was able to proactively refer 25% more at-risk patients for DXA scans within three months, leading to earlier osteoporosis diagnoses and preventative interventions, significantly improving patient outcomes and reducing future fracture-related healthcare costs.
Calculate Your Potential ROI with FREMML
Estimate the economic impact of implementing AI-driven fracture risk prediction in your organization. Adjust parameters to see personalized savings and efficiency gains.
AI Implementation Roadmap
Our structured approach ensures a smooth transition and rapid value realization when integrating FREMML into your operations.
Phase 1: Data Integration & Setup
Securely integrate existing healthcare registry data into the FREMML platform, ensuring data quality and privacy compliance. Establish the necessary infrastructure for model deployment.
Phase 2: Model Customization & Calibration
Tailor FREMML to specific regional guidelines and patient demographics. Calibrate risk thresholds and validate model performance against local datasets to ensure optimal accuracy.
Phase 3: Pilot Deployment & User Training
Roll out FREMML in a pilot program with selected primary care practices. Provide comprehensive training to physicians and administrative staff on interpreting AI outputs and integrating them into clinical workflows.
Phase 4: Full-Scale Rollout & Monitoring
Expand FREMML across the entire healthcare network. Continuously monitor model performance, collect user feedback, and conduct periodic recalibrations to maintain high predictive accuracy and clinical utility.
Ready to Transform Your Operations with AI?
Book a personalized strategy session with our experts to explore how FREMML can enhance your fracture risk assessment and patient care.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat